Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 862 shares of the stock in a transaction dated Monday, October 15th. The shares were sold at an average price of $105.26, for a total value of $90,734.12. Following the completion of the transaction, the senior vice president now owns 30,686 shares in the company, valued at approximately $3,230,008.36. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

NYSE:VAR opened at $108.65 on Thursday. The company has a market cap of $10.25 billion, a P/E ratio of 30.18, a PEG ratio of 3.15 and a beta of 0.78. Varian Medical Systems, Inc. has a 52-week low of $99.00 and a 52-week high of $130.29.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, July 25th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.05. The firm had revenue of $709.10 million for the quarter, compared to the consensus estimate of $663.19 million. Varian Medical Systems had a return on equity of 27.51% and a net margin of 4.07%. The firm’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.04 EPS. As a group, analysts expect that Varian Medical Systems, Inc. will post 4.45 earnings per share for the current fiscal year.

VAR has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. downgraded Varian Medical Systems from a “neutral” rating to an “underweight” rating and set a $105.00 price objective on the stock. in a report on Thursday, June 28th. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Tuesday, September 25th. Finally, Royal Bank of Canada set a $115.00 price objective on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, October 4th. Four investment analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $117.43.

A number of large investors have recently added to or reduced their stakes in the stock. Baird Financial Group Inc. grew its stake in Varian Medical Systems by 5.7% during the 1st quarter. Baird Financial Group Inc. now owns 8,006 shares of the medical equipment provider’s stock worth $981,000 after buying an additional 430 shares during the last quarter. First Republic Investment Management Inc. grew its stake in Varian Medical Systems by 10.2% during the 2nd quarter. First Republic Investment Management Inc. now owns 5,535 shares of the medical equipment provider’s stock worth $629,000 after buying an additional 511 shares during the last quarter. Dynamic Technology Lab Private Ltd grew its stake in Varian Medical Systems by 17.3% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 3,987 shares of the medical equipment provider’s stock worth $454,000 after buying an additional 587 shares during the last quarter. NorthCoast Asset Management LLC grew its stake in Varian Medical Systems by 4.7% during the 2nd quarter. NorthCoast Asset Management LLC now owns 15,010 shares of the medical equipment provider’s stock worth $1,707,000 after buying an additional 672 shares during the last quarter. Finally, SFE Investment Counsel grew its stake in Varian Medical Systems by 2.6% during the 2nd quarter. SFE Investment Counsel now owns 30,752 shares of the medical equipment provider’s stock worth $3,497,000 after buying an additional 779 shares during the last quarter. Hedge funds and other institutional investors own 92.44% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Read More: How to use beta for portfolio diversification

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.